02 November 2011
John Potthoff, PhD Appointed President and CEO of Theorem Clinical Research
(King of Prussia, PA—2 November 2011) Theorem Clinical Research, previously Omnicare Clinical Research, announced today that Dr. John Potthoff, PhD has been appointed as the company’s President and CEO. He succeeds Dr. James M. Pusey, MD who has been elevated to Executive Chairman to the Board of Directors after two formative and successful years in the President and CEO role.
“In the last nine months, Theorem Clinical Research has seen a significant increase in backlog,” said Dr. James M. Pusey, MD who led the newly independent CRO’s spin-out from former owner Omnicare, Inc. “The majority of this growth has been in the North America and Asia Pacific regions, as well as in our Technical Services and Medical Device Business Units. Our major investors are pleased with our progress and clients are excited by the way we’ve enhanced our organization to best support their needs.
John Potthoff has an impressive track record in the CRO industry, where he has demonstrated a talent for effectively operationalizing significant new business wins, and running an efficient, productive organization. Under his leadership, I’m confident Theorem will realize long-term success and profitability.”
“Theorem’s story is only just beginning,” continued Dr. Potthoff. “I’m pleased to be joining an organization that offers such strong growth potential. Theorem is unique in that it features a broad global footprint, yet it’s structured for agility and flexibility with a focus on the client’s needs. The specialized focus on Technical Services, Medical Devices and Pharmaceutics also creates another powerful value-add for our customers.”
With 18 years of experience in the CRO industry, Dr. Potthoff has a strong drug development background. Most recently, he held the role of Chief Operating Officer at INC Research. There, he achieved record year-on-year profits, operationally integrated seven acquisitions, and also helped negotiate the sale of the business in 2010. Prior to INC Research, Dr. Potthoff was President and CEO of Tanistry, Inc., a niche CRO acquired by INC Research in 2001, and, also spent seven years with PPD.